Horizon Discovery MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics As part of the initiative, MDIC will manufacture, validate, and distribute reference samples to support the validation of NGS-based cancer diagnostics. Sigma-Aldrich Licenses CRISPR-Cas9 Tech to Horizon Discovery The deal enables Horizon to support gene editing researchers who need cell-line engineering beyond loss-of-function CRISPR studies into CRISPR-mediated targeted knock-in. Horizon Discovery Licenses Gene-Edited Cell Line to Sanyou Biopharmaceuticals Sanyou will use the cell line in the development of preclinical antibody drug projects and to support its customers' human biotherapeutic products. PerkinElmer to Buy Horizon Discovery for $383M The deal allows PerkinElmer to expand its portfolio of automated life sciences discovery and applied genomics products to include gene editing and gene modulation tools. Horizon Discovery H1 Revenues Fall 14 Percent The gene editing and gene modulation technologies firm attributed the decline to the impact of the SARS-CoV-2 pandemic on its research reagents business. Jul 10, 2020 New Products Posted to GenomeWeb: Illumina, NIST, Horizon Discovery, More Apr 27, 2020 Horizon Discovery Revenues Up 8 Percent in 2019 Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Feb 4, 2020 Horizon Discovery Preliminary FY2019 Revenues Up 7 Percent Jan 30, 2020 Mammoth Biosciences Enters New Phase of Business Strategy With Horizon Deal, $45M Fundraise Premium Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Jan 14, 2020 Rutgers Licenses Base Editing Tech to Horizon Discovery Jan 13, 2020 Horizon Discovery, Mammoth Biosciences Sign Second CRISPR Tools Development Agreement Dec 13, 2019 Horizon Discovery, Mammoth Biosciences Team Up to Develop CRISPR Tools Dec 13, 2019 New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More Dec 3, 2019 Human Protein Atlas to Use Horizon Discovery Cell Models Sep 16, 2019 Horizon Discovery Revenues Up 14 Percent in H1 Mar 25, 2019 Horizon Discovery, St. George's University Hospital, EMQN to Develop NIPT Reference Material Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Sep 17, 2018 Horizon Discovery Revenues Double in H1 Aug 28, 2018 Horizon Discovery Begins Leveraging Vast Portfolio of Genome Editing Technology Premium Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium May 11, 2018 People in the News: Terry Pizzie, Stephanie Bywater, Michael Stocum May 9, 2018 Abcam Drops Takeover Bid for Horizon Discovery May 8, 2018 Horizon Discovery Preliminary 2017 Revenues Up 52 Percent Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.